Skip to main content
Premium Trial:

Request an Annual Quote

Digilab Inks Biomarker-Discovery Deal with Boehringer Ingelheim

NEW YORK, March 14 (GenomeWeb News) - Digilab BioVision today said it will work with Boehringer Ingelheim to identify new biomarkers.


Terms of the deal call for Digilab to use its Peptidomics technology to analyze quantitative peptide content of biological samples for Boehringer.


Additional details were not provided.


Digilab acquired Hanover, Germany-based BioVision last month to enhance its peptidome analysis technologies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.